Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis.
作者信息
Pérez de Llano Luis A, Golpe Rafael, Pérez-Ortiz Diego, Menéndez Rosario, España Yandiola Pedro P, Artaraz Amaia, Zalacain Rafael, Cilloniz Catia, Torres Antoni
机构信息
Pneumology Service, Lucus Augusti University Hospital, EOXI Lugo, Monforte, Cervo. C039 Biodiscovery Research Group HULA-USC, Health Research Institute of Santiago de Compostela (IDIS), Spain.
Pneumology Service, Lucus Augusti University Hospital, EOXI Lugo, Monforte, Cervo. C039 Biodiscovery Research Group HULA-USC, Health Research Institute of Santiago de Compostela (IDIS), Spain.
出版信息
Arch Bronconeumol. 2022 Mar;58(3):281-283. doi: 10.1016/j.arbres.2021.10.001. Epub 2021 Oct 24.
Abstract
摘要
相似文献
1
Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis.早期使用皮质类固醇激素可能对新冠肺炎肺炎住院患者有害：一项多中心倾向评分分析。
Arch Bronconeumol. 2022 Mar;58(3):281-283. doi: 10.1016/j.arbres.2021.10.001. Epub 2021 Oct 24.
2
Steroids and mortality in non-critically ill COVID-19 patients: a propensity score-weighted study in a Chilean cohort.类固醇与非危重症 COVID-19 患者的死亡率：智利队列中的倾向评分加权研究。
Int J Infect Dis. 2021 Nov;112:124-129. doi: 10.1016/j.ijid.2021.09.038. Epub 2021 Sep 20.
3
Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.系统皮质类固醇治疗对武汉重症和危重症 COVID-19 患者的死亡率的影响。
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa627.
4
5
Early Initiation of Feeding and In-Hospital Outcomes in Patients Hospitalized for Acute Heart Failure.急性心力衰竭住院患者早期喂养与院内结局。
Am J Cardiol. 2021 Apr 15;145:85-90. doi: 10.1016/j.amjcard.2020.12.082. Epub 2021 Jan 14.
6
Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia.甲型H7N9流感病毒性肺炎成人患者的辅助性皮质类固醇治疗
Crit Care Med. 2016 Jun;44(6):e318-28. doi: 10.1097/CCM.0000000000001616.
7
Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia.低至中等剂量皮质类固醇对甲型H1N1pdm09流感病毒性肺炎住院青少年及成人死亡率的影响。
Influenza Other Respir Viruses. 2017 Jul;11(4):345-354. doi: 10.1111/irv.12456. Epub 2017 Jun 9.
8
Real-Life Impact of Glucocorticoid Treatment in COVID-19 Mortality: A Multicenter Retrospective Study.糖皮质激素治疗对新冠病毒疾病死亡率的实际影响：一项多中心回顾性研究
J Clin Med. 2021 Oct 13;10(20):4678. doi: 10.3390/jcm10204678.
9
Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids.抗生素治疗与全身用皮质类固醇治疗的哮喘加重住院患者结局的关联。
JAMA Intern Med. 2019 Mar 1;179(3):333-339. doi: 10.1001/jamainternmed.2018.5394.
10
Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome.重症甲型 H1N1 流感肺炎和急性呼吸窘迫综合征患者早期应用皮质类固醇。
Am J Respir Crit Care Med. 2011 May 1;183(9):1200-6. doi: 10.1164/rccm.201101-0135OC. Epub 2011 Mar 4.
本文引用的文献
1
Corticosteroids Treatment of Patients with Coronavirus Disease 2019: A Propensity Score Matching Study.皮质类固醇治疗 2019 年冠状病毒病患者：一项倾向评分匹配研究。
Curr Med Sci. 2021 Feb;41(1):24-30. doi: 10.1007/s11596-021-2313-6. Epub 2021 Feb 13.
2
Corticosteroid treatment has no effect on hospital mortality in COVID-19 patients.皮质类固醇治疗对 COVID-19 患者的住院死亡率没有影响。
Sci Rep. 2021 Jan 13;11(1):1015. doi: 10.1038/s41598-020-80654-x.
3
The use of methylprednisolone in COVID-19 patients: A propensity score matched retrospective cohort study.COVID-19 患者中甲基泼尼松龙的使用：一项倾向评分匹配回顾性队列研究。
PLoS One. 2020 Dec 31;15(12):e0244128. doi: 10.1371/journal.pone.0244128. eCollection 2020.
4
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes.COVID-19 患者中皮质类固醇的使用：临床结局的系统评价和荟萃分析。
Crit Care. 2020 Dec 14;24(1):696. doi: 10.1186/s13054-020-03400-9.
5
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.COVID-19 重症患者的皮质类固醇治疗：一项倾向评分匹配研究。
Expert Rev Respir Med. 2021 Apr;15(4):543-552. doi: 10.1080/17476348.2021.1856659. Epub 2021 Feb 1.
6
Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.糖皮质激素治疗 2019 冠状病毒病相关急性呼吸窘迫综合征：一项倾向评分分析的队列研究。
Crit Care. 2020 Nov 10;24(1):643. doi: 10.1186/s13054-020-03340-4.
7
Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.皮质类固醇治疗急性呼吸窘迫综合征的重症 COVID-19 患者。
J Clin Invest. 2020 Dec 1;130(12):6417-6428. doi: 10.1172/JCI140617.
8
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
9
Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19.COVID-19 住院成人患者的中低剂量皮质类固醇治疗。
Clin Microbiol Infect. 2021 Jan;27(1):112-117. doi: 10.1016/j.cmi.2020.09.045. Epub 2020 Sep 29.
10
Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.系统皮质类固醇治疗对武汉重症和危重症 COVID-19 患者的死亡率的影响。
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa627.
Zotero 插件